博士眼镜连锁股份有限公司外部信息报送及使用管理制度 博士眼镜连锁股份有限公司 外部信息报送及使用管理制度 第一章 总则 第一条 为了进一步加强博士眼镜连锁股份有限公司（以下简称"公司"或 "本公司"）定期报告、临时报告及重大事项在编制、审议和披露期间的外部信 息使用人的管理，规范外部信息报送管理事务，确保公平信息披露，杜绝泄露内 幕信息、内幕交易等违法违规行为，根据《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司信息披露管理办法》《深圳证券交易所创业板股票上市 规则》等法律、法规、规范性文件和《博士眼镜连锁股份有限公司章程》（以下 简称"《公司章程》"）、《博士眼镜连锁股份有限公司内幕信息知情人登记管理制 度》等有关规定，结合本公司的实际情况，制定本制度。 第二条 本制度的适用范围包括本公司及公司各部门、分公司、子公司，公 司的董事、高级管理人员及其他相关人员，公司对外报送信息涉及的外部单位或 个人。 第三条 本制度所指信息是指所有对公司证券及其衍生品种交易价格可能产 生较大影响的信息，包括但不限于：定期报告、临时报告、财务数据、统计数据 及需要报批的重大事项等。 第四条 公司董事会是信息对外报送 ...

博士眼镜连锁股份有限公司董事会专门委员会实施细则 博士眼镜连锁股份有限公司 第六条 提名委员会成员由三名董事组成，其中独立董事两名；设主任委员 （召集人）一名，由独立董事委员担任。 第七条 薪酬与考核委员会成员由三名董事组成，其中独立董事两名；设主 任委员（召集人）一名，由独立董事委员担任。 董事会专门委员会实施细则 第一章 总则 第一条 为提高博士眼镜连锁股份有限公司（以下简称"公司"）的决策科 学性，增强公司核心竞争力，完善公司治理结构，根据《中华人民共和国公司法》 《博士眼镜连锁股份有限公司章程》（以下简称"《公司章程》"）及其他有关 规定，特制订本细则。 第二条 公司董事会下设审计委员会、战略委员会、提名委员会、薪酬与考 核委员会。专门委员会成员全部由董事组成，其中审计委员会、提名委员会、薪 酬与考核委员会中独立董事应过半数并由独立董事担任召集人，审计委员会的召 集人应当为独立董事中的会计专业人士，且成员应当为不在公司担任高级管理人 员的董事。 第三条 专门委员会对董事会负责，依照《公司章程》和董事会授权履行职 责，专门委员会的提案应当提交董事会审议决定。 公司董事会应履行对其下属委员会的监督职能，不 ...

博士眼镜连锁股份有限公司会计师事务所选聘制度 博士眼镜连锁股份有限公司 第一条 为规范博士眼镜连锁股份有限公司（以下简称"公司"）选聘（含续 聘、改聘，下同）执行财务报表审计业务的会计师事务所相关行为，保证财务信 息质量，维护股东利益，根据《中华人民共和国公司法》《中华人民共和国会计 法》《中华人民共和国证券法》（以下简称"《证券法》"）《深圳证券交易所创业板 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》《国有企业、上市公司选聘会计师事务所管理办法》及《博士眼 镜连锁股份有限公司章程》（以下简称"《公司章程》"），结合公司实际情况，制 定本制度。 第二条 公司选聘执行财务报表审计业务的会计师事务所相关行为，应当遵 照本制度，履行选聘程序，披露相关信息。 第三条 公司选聘会计师事务所应当经董事会审计委员会审议同意后，提交 董事会审议，并由股东会决定，董事会不得在股东会决定前委任会计师事务所。 在公司董事会、股东会审议批准前，公司不得聘请会计师事务所开展财务报表审 计业务。 第四条 公司控股股东、实际控制人不得在公司董事会、股东会审议前，向 公司指定会计师事务所，不得 ...

投资者关系管理制度 第一章 总 则 博士眼镜连锁股份有限公司投资者关系管理制度 博士眼镜连锁股份有限公司 博士眼镜连锁股份有限公司投资者关系管理制度 第一条 为了切实加强博士眼镜连锁股份有限公司（以下简称"公司"）与投资 者和潜在投资者（以下统称"投资者"）之间的沟通，促进投资者对公司的了解， 进一步完善公司法人治理结构，提升公司的投资价值，实现公司价值和股东利益最 大化，切实保护投资者特别是中小投资者合法权益，根据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司投资者关系管理工作指引》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第2号—创业板上 市公司规范运作》等有关法律法规、规范性文件以及《博士眼镜连锁股份有限公司 章程》（以下简称"《公司章程》"）的有关规定，结合公司实际情况，特制定本 制度。 第四条 投资者关系管理工作的基本原则如下： 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交流 和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对公司了 解和认同，以提升公司治理水平和企业整体价值，实现尊重投资者、回报投资者、 保护投资 ...

Core Insights - The professional chain sector experienced a decline of 0.89% on October 28, with Huazhi Wine leading the drop [1] - The Shanghai Composite Index closed at 3988.22, down 0.22%, while the Shenzhen Component Index closed at 13430.1, down 0.44% [1] Sector Performance - The professional chain sector saw a net outflow of 155 million yuan from main funds, while retail investors contributed a net inflow of 124 million yuan [1] - Key stocks in the sector showed varied performance, with Kid King rising by 0.55% to close at 10.88 yuan, while Huazhi Wine fell by 1.96% to 21.01 yuan [1] Fund Flow Analysis - Main funds showed significant outflows in several stocks, with Aishide experiencing the largest outflow of 87.87 million yuan, accounting for 19.84% of its total [2] - Retail investors favored stocks like Aishide and Huazhi Wine, with net inflows of 65.27 million yuan and 21.15 million yuan respectively, indicating a preference for these stocks despite main fund outflows [2]

Core Insights - The professional chain sector experienced a decline of 1.27% on October 24, with Tianyin Holdings leading the drop [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Sector Performance - The professional chain sector saw mixed performance among individual stocks, with 博士眼镜 (Doctor Glasses) rising by 0.85% to a closing price of 29.77, while 天音控股 (Tianyin Holdings) fell by 2.88% to 10.13 [1] - The trading volume for the sector was significant, with 孩子王 (Kids King) recording a volume of 334,700 shares and a transaction value of 365 million yuan [1] Capital Flow - The professional chain sector experienced a net outflow of 41.16 million yuan from institutional investors, while retail investors saw a net inflow of 39.68 million yuan [1] - Individual stock capital flows showed that 博士眼镜 had a net inflow of over 9.58 million yuan from institutional investors, while 天音控股 faced a net outflow of 30.03 million yuan [2]

Core Insights - The professional chain sector increased by 0.64% on October 22, with Tianyin Holdings leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - Tianyin Holdings (000829) closed at 10.31, up 5.31% with a trading volume of 294,400 shares and a transaction value of 296 million [1] - Aishide (002416) closed at 12.93, up 2.54% with a trading volume of 426,300 shares and a transaction value of 540 million [1] - Aizhi Room (603214) remained unchanged at 18.60 with a trading volume of 27,600 shares and a transaction value of 51 million [1] - Doctor Glasses (300622) closed at 29.59, down 1.00% with a trading volume of 39,600 shares and a transaction value of 117 million [1] - Jifeng Technology (300022) closed at 8.50, down 1.16% with a trading volume of 91,300 shares and a transaction value of 77.6 million [1] - Huazhi Wine (300755) closed at 18.66, down 1.27% with a trading volume of 27,100 shares and a transaction value of 50.7 million [1] - Kids Wang (301078) closed at 10.86, down 2.51% with a trading volume of 330,000 shares and a transaction value of 362 million [1] Capital Flow - The professional chain sector experienced a net outflow of 41.61 million from institutional investors, while retail investors saw a net inflow of 55.54 million [1] - Tianyin Holdings had a net inflow of 35.36 million from institutional investors, while retail investors had a net outflow of 17.06 million [2] - Aishide saw a net inflow of 2.14 million from institutional investors, with retail investors also experiencing a net outflow of 1.29 million [2] - Doctor Glasses had a significant net outflow of 16.90 million from institutional investors, but retail investors had a net inflow of 22.07 million [2] - Kids Wang faced a net outflow of 59.22 million from institutional investors, while retail investors had a net inflow of 50.26 million [2]

Core Viewpoint - Dr. Optical's stock price has experienced a decline of 21.28% year-to-date, with recent fluctuations indicating a potential recovery in the short term [2] Group 1: Stock Performance - As of October 21, Dr. Optical's stock rose by 2.00%, reaching a price of 30.09 CNY per share, with a total market capitalization of 6.856 billion CNY [1] - The stock has seen a net inflow of 3.8985 million CNY from major funds, with large orders accounting for 19.30% of total purchases [1] - Over the past five trading days, the stock has increased by 1.90%, while it has decreased by 13.66% over the past 20 days and 12.38% over the past 60 days [2] Group 2: Financial Performance - For the first half of 2025, Dr. Optical reported a revenue of 686 million CNY, reflecting a year-on-year growth of 14.22%, and a net profit attributable to shareholders of 56.0334 million CNY, up by 6.97% [3] - Since its A-share listing, the company has distributed a total of 464 million CNY in dividends, with 204 million CNY distributed over the past three years [4] Group 3: Shareholder Structure - As of June 30, 2025, the number of shareholders increased to 53,800, with an average of 2,892 circulating shares per person, marking an increase of 19.81% [3] - Notable new institutional shareholders include Guangfa Innovation Upgrade Mixed Fund and Minsheng Jia Yin Continuous Growth Mixed Fund, both entering the top ten circulating shareholders [4]

Core Insights - The professional chain sector experienced a rise of 2.21% on October 20, with Aishide leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Sector Performance - Aishide (002416) closed at 12.63, with a gain of 6.05% and a trading volume of 589,300 shares, amounting to a transaction value of 740 million [1] - Tianyin Holdings (000829) closed at 9.77, up 2.63%, with a trading volume of 229,300 shares and a transaction value of 224 million [1] - Aiyingshi (603214) closed at 18.34, increasing by 2.00%, with a trading volume of 56,900 shares and a transaction value of 104 million [1] - Huazhi Wine (300755) closed at 18.78, up 0.97%, with a trading volume of 36,800 shares and a transaction value of 69.4 million [1] - Boshiyanjing (300622) closed at 29.50, with a slight increase of 0.24%, trading 49,300 shares for a value of 145 million [1] - Jifeng Technology (300022) closed at 8.78, up 0.23%, with a trading volume of 95,600 shares and a transaction value of 83.87 million [1] - Haiziwang (301078) closed at 11.23, with a minor decline of 0.09%, trading 383,400 shares for a value of 428 million [1] Capital Flow - The professional chain sector saw a net inflow of 52.61 million from institutional investors, while retail investors experienced a net outflow of 60.09 million [1] - Aishide had a net outflow of 53.71 million from institutional investors, with a net inflow of 20.75 million from speculative funds [2] - Tianyin Holdings had a net inflow of 14.59 million from institutional investors, while retail investors saw a net outflow of 21.54 million [2] - Aiyingshi experienced a net inflow of 14.85 million from institutional investors, with a net outflow of 12.04 million from retail investors [2] - Jifeng Technology had a net outflow of 7.15 million from institutional investors, while speculative funds saw a net inflow of 7.89 million [2] - Haiziwang had a net outflow of 20.24 million from institutional investors, with a net inflow of 21.67 million from speculative funds [2]

Core Viewpoint - Dr. Optical's stock has experienced a significant decline this year, with a year-to-date drop of 22.22%, indicating potential challenges in the retail optical market [1][2]. Financial Performance - For the first half of 2025, Dr. Optical achieved a revenue of 686 million yuan, representing a year-on-year growth of 14.22%, while the net profit attributable to shareholders was 56.03 million yuan, up 6.97% year-on-year [2]. - The company has distributed a total of 464 million yuan in dividends since its A-share listing, with 204 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 14, Dr. Optical's stock price was 29.73 yuan per share, with a market capitalization of 6.774 billion yuan. The stock has seen a trading volume of 150 million yuan and a turnover rate of 3.20% [1]. - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) twice this year, with the most recent instance on February 21, where it recorded a net buy of -235 million yuan [1]. Shareholder Information - As of June 30, the number of shareholders for Dr. Optical increased to 53,800, a rise of 9.25% from the previous period, with an average of 2,892 circulating shares per shareholder, up 19.81% [2]. - Notable new institutional shareholders include Guangfa Innovation Upgrade Mixed Fund and Minsheng Jia Yin Continuous Growth Mixed Fund, which are now among the top ten circulating shareholders [3]. Business Overview - Dr. Optical, established on April 23, 1997, and listed on March 15, 2017, primarily engages in optical retail, with its revenue composition being 68.65% from optical glasses and fitting services, 19.47% from finished lens products, and 10.80% from contact lens products [1].